Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
With a market cap of 31.44B, Natera(NTRA) trades at $227.29. The stock has a price-to-earnings ratio of -99.99.
During the trading session on 2025-12-16, Natera(NTRA) shares reached a daily high of $229.22 and a low of $225.80. At a current price of $227.29, the stock is +0.7% higher than the low and still -0.8% under the high.
Trading activity shows a volume of 197.85K, compared to an average daily volume of 1.27M.
The stock's 52-week range extends from a low of $125.38 to a high of $246.90.
The stock's 52-week range extends from a low of $125.38 to a high of $246.90.
NTRA News
NeoGenomics (NEO) announced that Natera (NTRA) voluntarily dismissed its appeal of the North Carolina District Court’s August 2025 ruling. The dismissal will le...
Natera (NTRA) shares have quietly outpaced much of the biotech space this year, climbing strongly on the back of double digit revenue growth and rapidly improvi...
Natera (NTRA) and Medica Scientia Innovation Research announced their collaboration on the MiRaDoR study, which is a multicenter, phase II clinical trial in hor...
Analyst ratings
86%
of 22 ratingsMore NTRA News
Natera Inc. (NASDAQ:NTRA) on Wednesday revealed initial translational research results from the international randomized Phase 3 PALLAS study. Data were presen...
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks Quick Read Natera (NTRA) grew revenue 34.66% year-over-year in Q3 2025 and has rall...
Natera (NTRA) “announced initial translational research results from the international randomized Phase III PALLAS study. Presented today at the San Antonio Bre...